WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center forContinue Reading

U.S. could soon approve COVID boosters for all adults. Sources say the move from the U.S. Food and Drug Administration could come as early as Thursday, making tens of millions more Americans eligible for the immune-strengthening doses.Read more Demand for liver transplants is soaring. More older folks are winding upContinue Reading

WEDNESDAY, Nov. 17, 2020 (HealthDay News) — More older folks are winding up on liver transplant waiting lists than ever before, as obesity and alcoholism supersede hepatitis C as the main cause of liver failure in the United States. The percentage of liver transplant candidates aged 65 or older roseContinue Reading